Motilal Oswal Highlights Top Stock Picks for Investors: HCL, Endurance Tech, IIFL Finance, and Ipca Labs
February 14, 2025, 10:42 IST
In the latest investment insights provided by brokerage firm Motilal Oswal, four stocks have been highlighted as top picks for potential growth and returns. This publication aims to delve into the reasons behind Motilal Oswal’s bullish outlook on these stocks, which includes industry leaders HCL Technologies, Endurance Technologies, IIFL Finance, and Ipca Laboratories.
HCL Technologies: A Stable Outlook Amidst Uncertainty
Motilal Oswal has issued a ‘Buy’ recommendation for HCL Technologies, assigning a target price of Rs 2,200. The management at HCL has indicated a trend where deal durations are shortening, with larger contracts being divided into smaller components. Nevertheless, they maintain a robust pipeline, and recent trends show improving deal momentum.
The brokerage acknowledges the near-term uncertainties but remains optimistic about HCL’s growth potential. They project a 6.5% year-on-year growth in constant currency for FY26, despite a softer performance expected in the third quarter. Enhanced discretionary spending could provide a further upside to these projections, according to Motilal Oswal Financial Services.
Endurance Technologies: Strategic Growth in Auto-Ancillary Sector
Within the auto-ancillary sector, Endurance Technologies stands out as Motilal Oswal’s premier pick. The brokerage has reiterated a ‘Buy’ rating with a target price of Rs 2,400. They express confidence in the company’s strategic push into the four-wheeler sector, which is expected to account for 45% of sales by FY30.
Key growth drivers for Endurance Technologies include a steady recovery in two-wheeler demand, an expanding presence in passenger vehicles, and a robust order backlog from Europe. These factors collectively contribute to a favorable outlook for the company within its industry.
IIFL Finance: Capitalizing on Gold Loan Success
IIFL Finance has also received a ‘Buy’ rating from Motilal Oswal, primarily driven by strong growth in its gold loan portfolio, which has surged 40% sequentially. The company’s management has indicated that with previous constraints on the gold lending business now lifted, IIFL is positioned for a significant phase of growth in its secured product offerings such as gold loans and loan against property (LAP). As gold prices remain firm, trading near all-time highs, this segment is expected to act as a significant driver of growth for the company.
Ipca Laboratories: Strengthening Market Position
Finally, Motilal Oswal has placed a ‘Buy’ call on Ipca Laboratories with a target price set at Rs 1,940. The brokerage has increased its earnings estimates by 4% for FY25, 3% for FY26, and 2% for FY27. This adjustment reflects the company’s rising share of higher-margin products, improved operating leverage in the US market, and a revival in its South African business.
The firm believes that Ipca is on course to revive its US operations from its own site, as well as effectively integrate and scale Unichem’s operations. Furthermore, efforts to enhance offerings and gain market share in the domestic formulation (DF) segment, in addition to driving operational improvements, support the projected 28% earnings compound annual growth rate (CAGR) over FY25-27.
Conclusion
Motilal Oswal’s insights reflect a carefully curated selection of stocks that highlight potential growth opportunities across various sectors. Investors looking to enhance their portfolios may find value in the strategies and projections outlined by the brokerage firm. For continued updates on market trends, stock recommendations, and investment advice, readers are encouraged to follow financial news platforms and expert analysis.
For further details about Nifty 50 and BSE Sensex levels, as well as the latest insights into stock market dynamics, interested parties may wish to download dedicated financial news applications for timely alerts and strategies tailored to enhancing investment outcomes.
Share this article:
